CD55 acts as a cellular ligand for CD97; strong CD97 expression by tumour cells at the invasive front has been correlated with a higher clinical stage and increased lymph vessel invasion compared to cases with uniform CD97 staining throughout the tumour [226]. The gene discussed is CD55; the disease is neoplasm.